ALT-29.09%7.7%
ARQT+88.47%7.7%
ARWR+345.39%7.7%
AVXL-75.85%7.7%
BCRX+20.72%7.7%
BHVN+11.71%7.7%
HALO+36.42%7.7%
KNSA+125.84%7.7%
KROS-16.86%7.7%
KYMR+163.22%7.7%
SPRY-56.17%7.7%
TERN+69.61%7.7%
VRDN+17.92%7.7%
As of Jul 10, 2026, 7:14 AM ET
Biotech '24: Pharma/Therapeutics Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc.ARWR | 7.7% | 2.02% | -2.03% | 4.35% | 4.43% | 26.53% | 32.76% | 561.94% | 345.39% | $11.83B |
Kymera Therapeutics, Inc.KYMR | 7.7% | -2.51% | 4.24% | 8.85% | 4.20% | 52.94% | 30.27% | 351.44% | 163.22% | $9.79B |
Halozyme Therapeutics, Inc.HALO | 7.7% | -0.14% | -2.18% | 1.87% | 2.09% | 16.82% | 13.07% | 24.75% | 36.42% | $9.33B |
Kiniksa Pharmaceuticals International, plcKNSA | 7.7% | -3.41% | 0.96% | 4.76% | 3.97% | 58.50% | 46.95% | 199.22% | 125.84% | $4.91B |
Arcutis Biotherapeutics, Inc.ARQT | 7.7% | 1.58% | 0.98% | 7.55% | 11.38% | -0.90% | 6.71% | 73.37% | 88.47% | $3.60B |
BioCryst Pharmaceuticals, Inc.BCRX | 7.7% | 2.85% | -3.51% | 12.25% | 11.09% | 37.44% | 22.51% | 44.28% | 20.72% | $2.25B |
Viridian Therapeutics, Inc.VRDN | 7.7% | -1.86% | 1.71% | 7.50% | 9.31% | -35.09% | -31.25% | 54.55% | 17.92% | $1.82B |
Biohaven Ltd.BHVN | 7.7% | -0.03% | 0.90% | 12.31% | 6.54% | 48.72% | 45.75% | -29.10% | 11.71% | $1.78B |
ARS Pharmaceuticals, Inc.SPRY | 7.7% | 0.57% | -2.72% | -7.94% | -0.76% | -32.36% | -15.09% | -39.62% | -56.17% | $782.5M |
Terns Pharmaceuticals, Inc.TERN | 7.7% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 231.73% | 69.61% | $744.0M |
Keros Therapeutics, Inc.KROS | 7.7% | -0.33% | 3.08% | 10.06% | 10.57% | -40.91% | -15.22% | 19.82% | -16.86% | $384.9M |
Altimmune, Inc.ALT | 7.7% | 0.64% | 0.32% | 6.12% | -0.95% | -13.57% | -27.61% | -34.73% | -29.09% | $275.4M |
Anavex Life Sciences Corp.AVXL | 7.7% | 1.30% | 0.00% | 3.85% | 4.65% | -24.16% | -39.05% | -68.46% | -75.85% | $250.2M |
| Theme return | — | 0.05% | 0.13% | 5.50% | 5.29% | 9.70% | 7.20% | 83.56% | 41.25% | — |
| Average | 7.7% | 0.05% | 0.13% | 5.50% | 5.12% | 7.23% | 5.37% | 106.86% | 53.95% | $3.67B |
| Median | 7.7% | 0.00% | 0.32% | 6.12% | 4.43% | 0.00% | 6.71% | 44.28% | 20.72% | $1.82B |
| Std Dev | 0.0% | 1.72% | 2.18% | 5.27% | 4.24% | 34.00% | 28.23% | 176.26% | 107.01% | $3.90B |
| Min | 7.7% | -3.41% | -3.51% | -7.94% | -0.95% | -40.91% | -39.05% | -68.46% | -75.85% | $250.2M |
| Max | 7.7% | 2.85% | 4.24% | 12.31% | 11.38% | 58.50% | 46.95% | 561.94% | 345.39% | $11.83B |
| % Positive Tickers | 46.15% | 53.85% | 84.62% | 76.92% | 46.15% | 53.85% | 69.23% | 69.23% |
About this theme
Biotech '24: Pharma/Therapeutics tracks 13 publicly listed stocks in this theme. Sample tickers: ALT, ARQT, ARWR, AVXL, BCRX, BHVN, HALO, KNSA, KROS, KYMR, SPRY, TERN, and 1 more. Use the table below for the full list.